Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PRINSEN, B. H. C. M. T.
Right arrow Articles by RABELINK, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PRINSEN, B. H. C. M. T.
Right arrow Articles by RABELINK, T. J.
J Am Soc Nephrol 12:1017-1025, 2001
© 2001 American Society of Nephrology

Transferrin Synthesis Is Increased in Nephrotic Patients Insufficiently to Replace Urinary Losses

BERTHIL H. C. M. T. PRINSEN*,{dagger},{ddagger}, MONIQUE G. M. DE SAIN-VAN DER VELDEN{ddagger}, GEORGE A. KAYSEN§, HELMA W. H. C. STRAVER{ddagger}, HERMAN J. M. VAN RIJN{dagger}, FRANS STELLAARD||, RUUD BERGER{ddagger} and TON J. RABELINK*

* Department of Vascular Medicine and Metabolism, University Medical Center Utrecht, Utrecht, The Netherlands
{dagger} Department of Clinical Chemistry, University Medical Center Utrecht, Utrecht, The Netherlands
{ddagger} Department of Metabolic Diseases, University Medical Center Utrecht, Utrecht, The Netherlands
§ Department of Medicine, Division of Nephrology, University of California-Davis, Davis, and Department of Veterans Affairs Northern California System of Clinics, Mather, California
|| Department of Nutrition and Metabolism, University Hospital Groningen, Groningen, The Netherlands.

Correspondence to Dr. Monique G. M. de Sain-van der Velden, University Medical Center Utrecht, Department of Metabolic Diseases, H.P. KC-02.069.1, P.O. Box 85090, 3508 AB, Utrecht, The Netherlands. Phone: 31-30-2504294; Fax: 31-30-2504295; E-mail: M.G.deSain{at}lab.azu.nl

Abstract. The urinary loss of transferrin is sufficient to reduce plasma transferrin concentrations in the nephrotic syndrome. Hypotransferrinemia may lead to iron loss and microcytic anemia. The mechanism responsible for the hypotransferrinemia in the nephrotic syndrome is, however, unknown. In the present study, synthesis rate of transferrin was measured in vivo in nephrotic patients (n = 7) compared with control subjects (n = 6) using L-[1-13C]-valine. Plasma transferrin and iron concentration in the patients were significantly lower than in control subjects (transferrin, 1.39 ± 0.08 versus 2.57 ± 0.11 g/L, P < 0.0001; iron, 10.2 ± 0.8 versus 21.1 ± 4.5 µmol/L, P = 0.02). Furthermore, albuminuria correlated with transferrinuria (r2 = 0.901, P = 0.001). The absolute synthesis rate of transferrin was increased in the patients (10.0 ± 1.1 versus 7.4 ± 0.7 mg/kg per d, P = 0.07), although this value failed to achieve significance. C-reactive protein, plasma iron, and proteinuria did not correlate with transferrin synthesis. In contrast, transferrin synthesis correlated with albumin synthesis (r2 = 0.648, P = 0.03; n = 7). The present study indicates that increased transferrin synthesis occurs in nephrotic patients but is insufficient to compensate for urinary losses. Because, overall, no significant relationship was found between transferrin synthesis and either C-reactive protein or iron, it is unlikely that inflammation suppresses or that iron deficiency stimulates increased transferrin synthesis in these patients. The correlation between transferrin synthesis and albumin synthesis suggests that transferrin synthesis is a component of a general response in hepatic protein synthesis in the nephrotic syndrome. This suggests that a therapeutic approach to maximize plasma transferrin concentrations in nephrotic patients should be aimed primarily at reducing urinary protein excretion.




This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
M. S. Joy, M. La, and Bo Xiao
Individualizing Therapy in Patients With Chronic Kidney Disease
Journal of Pharmacy Practice, June 1, 2008; 21(3): 225 - 236.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
A. J. W. Branten, D. W. Swinkels, I. S. Klasen, and J. F. M. Wetzels
Serum ferritin levels are increased in patients with glomerular diseases and proteinuria
Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2754 - 2760.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. H. Bisschop, M. G. M. de Sain-van der Velden, F. Stellaard, F. Kuipers, A. J. Meijer, H. P. Sauerwein, and J. A. Romijn
Dietary Carbohydrate Deprivation Increases 24-Hour Nitrogen Excretion without Affecting Postabsorptive Hepatic or Whole Body Protein Metabolism in Healthy Men
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3801 - 3805.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Yang, K. Mori, J. Y. Li, and J. Barasch
Iron, lipocalin, and kidney epithelia
Am J Physiol Renal Physiol, July 1, 2003; 285(1): F9 - F18.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP